SKIN

SkinHealth Systems Inc. Class A Common Stock

SKIN
Closed
$0.93
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

The Beauty Health Co. engages in the design, development, manufacture, marketing, and sale of esthetic technologies and products. The company is headquartered in Long Beach, California and currently employs 613 full-time employees. The company went IPO on 2020-02-10. The Company, anchored by Hydrafacial, a professional skincare treatment, and supported by complementary offerings including SkinStylus microneedling and HydraScalp with Keravive, combines advanced device technology, proprietary consumables, and clinical validation to deliver treatment experiences through an omnichannel network of providers worldwide. Hydrafacial specializes in the category of hydradermabrasion with its patented delivery system that cleanses, extracts and hydrates the skin with proprietary solutions and serums. The treatment extends to the scalp through its HydraScalp powered by Keravive treatment, which is designed to support the hair's natural growth. SkinStylus specializes in nano-channeling and microneedling where its products are designed to provide either a non-invasive (nano-channeling) or minimally-invasive (microneedling) skin treatment to individuals.
Country

US

CEO

Mr. Pedro Malha

IPO date

2020

Employees

613

ISIN

US88331L1089

Key stats

Open

$0.91

Volume

3.55M

Market cap

$136.08M

Prev. close

$0.94

Impl / hst vl

-

Open interest

$0.00

$0.91

Day’s Range

$0.94

$0.55

52W Range

$1.59

Valuation

38
Valuation score
Overvalued
P/E
-
P/S
0.46
P/B
2.46
Current ratio
1.79
Debt / Equity
2.53
ROE
-9.46%
Gross margin
68.46%
Income growth
-18.19%
FCF growth
-152.14

Analysts estimates

Consensus rating
Hold

The average rating from top 8 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$1.37
The top 8 analysts forecasts that 12-month price may increase by 47.15%, with a low of $1.01 and a high of $2.10
$1.01
Low
$1.37
Avg
$2.10
High
Current price

Earnings

Q1 ‘26 revenue
$64.91M
Q1 ‘26 net income
-$6.63M
Revenue
Net income
Previous EPS
-$0.05
Estimate EPS
-$0.02
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply